Frew JW - Search Results

1

No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.

Purdie KJ, Pourreyron C, Fassihi H, Cepeda-Valdes R, Frew JW, Volz A, Weissenborn SJ, Pfister H, Proby CM, Bruckner-Tuderman L, Murrell DF, Salas-Alanis JC, McGrath JA, Leigh IM, Harwood CA, South AP. Purdie KJ, et al. Among authors: frew jw. J Invest Dermatol. 2010 Dec;130(12):2853-5. doi: 10.1038/jid.2010.243. Epub 2010 Aug 26. J Invest Dermatol. 2010. PMID: 20739945 Free PMC article. No abstract available.

2

Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.

Frew JW, Martin LK, Nijsten T, Murrell DF. Frew JW, et al. Br J Dermatol. 2009 Dec;161(6):1323-30. doi: 10.1111/j.1365-2133.2009.09347.x. Epub 2009 Jun 11. Br J Dermatol. 2009. PMID: 19681875

3

A ski and adventure camp for young patients with severe forms of epidermolysis bullosa.

Nading MA, Lahmar JJ, Frew JW, Ghionis N, Hanley M, Welch AK, Murrell DF. Nading MA, et al. Among authors: frew jw. J Am Acad Dermatol. 2009 Sep;61(3):508-11. doi: 10.1016/j.jaad.2008.12.004. J Am Acad Dermatol. 2009. PMID: 19700016 Clinical Trial.

4

Quality of life measurements in epidermolysis bullosa: tools for clinical research and patient care.

Frew JW, Murrell DF. Frew JW, et al. Dermatol Clin. 2010 Jan;28(1):185-90. doi: 10.1016/j.det.2009.10.019. Dermatol Clin. 2010. PMID: 19945634 Review.

5

Categorizing immunoflourescence mapping in epidermolysis bullosa with pyloric atresia: Use as a broad prognostic indicator.

Frew JW, Dopping-Hepenstal PJ, McGrath JA. Frew JW, et al. Australas J Dermatol. 2010 Aug;51(3):212-4. doi: 10.1111/j.1440-0960.2010.00666.x. Australas J Dermatol. 2010. PMID: 20695865

6

Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis.

Frew JW, Murrell DF. Frew JW, et al. Dermatol Clin. 2011 Jul;29(3):419-25, viii. doi: 10.1016/j.det.2011.03.018. Dermatol Clin. 2011. PMID: 21605807 Review.

7

Corticosteroid use in autoimmune blistering diseases.

Frew JW, Murrell DF. Frew JW, et al. Dermatol Clin. 2011 Oct;29(4):535-44. doi: 10.1016/j.det.2011.06.004. Epub 2011 Aug 6. Dermatol Clin. 2011. PMID: 21924995

8

Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.

Frew JW, Martin LK, Murrell DF. Frew JW, et al. Dermatol Clin. 2011 Oct;29(4):599-606. doi: 10.1016/j.det.2011.07.001. Dermatol Clin. 2011. PMID: 21925004 Review.

9

Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).

Frew JW, Murrell DF. Frew JW, et al. Dermatol Clin. 2011 Oct;29(4):607-12. doi: 10.1016/j.det.2011.06.016. Epub 2011 Aug 15. Dermatol Clin. 2011. PMID: 21925005 Review.

10

Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen.

Frew J, Lim SW, Klausseger A, Chow CW, Tran K, Su J, Orchard D, Varigos G, Sawamura D, Nishie W, Shimizu H, Murrell DF. Frew J, et al. Australas J Dermatol. 2011 Nov;52(4):e1-4. doi: 10.1111/j.1440-0960.2010.00684.x. Epub 2010 Aug 24. Australas J Dermatol. 2011. PMID: 22070715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters